Belpointe Asset Management »

Tg Therapeutics shares owned by Belpointe Asset Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Belpointe Asset Management from 13F filings

Historical chart of Belpointe Asset Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Belpointe Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Belpointe Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.8M 51k 54.94
2023-03-31 $102k 6.8k 15.04
2022-12-31 $25k 2.1k 11.83
2018-09-30 $243k 43k 5.59